|
US4602705A
(en)
|
1981-11-09 |
1986-07-29 |
Lucas Industries Public Limited Company |
Flywheel mechanism for anti-skid braking systems
|
|
US5364773A
(en)
|
1991-03-07 |
1994-11-15 |
Virogenetics Corporation |
Genetically engineered vaccine strain
|
|
US4652639A
(en)
|
1982-05-06 |
1987-03-24 |
Amgen |
Manufacture and expression of structural genes
|
|
US4518584A
(en)
|
1983-04-15 |
1985-05-21 |
Cetus Corporation |
Human recombinant interleukin-2 muteins
|
|
US6100064A
(en)
|
1984-04-06 |
2000-08-08 |
Chiron Corporation |
Secreted viral proteins useful for vaccines and diagnostics
|
|
US6001977A
(en)
|
1984-08-22 |
1999-12-14 |
The United States Of America As Represented By The Department Of Health And Human Services |
Cloning and expression of HTLV-III DNA
|
|
US5032510A
(en)
|
1984-09-26 |
1991-07-16 |
Eli Lilly And Company |
Method for expression and secretion in bacillus
|
|
CA1341482C
(en)
|
1984-10-31 |
2005-05-10 |
Paul A. Luciw |
Process for preparing fragments of aids-associated retroviruses
|
|
JPS62501263A
(ja)
|
1984-11-29 |
1987-05-21 |
スクリツプス クリニツク アンド リサ−チ フアウンデ−シヨン |
脱グリコシル化ウイルス糖タンパク質に関連するポリペプチド類および抗体
|
|
ATE138100T1
(de)
|
1984-12-24 |
1996-06-15 |
Genentech Inc |
Fusionen von aids-verwandten polypeptiden
|
|
DK171119B1
(da)
|
1985-04-19 |
1996-06-17 |
Hoffmann La Roche |
AIDS-viruskappeprotein, ekspressionsvektor bærende viruskappeproteinet, transformanter transformeret med ekspressionsvektoren, fremgangsmåde til fremstilling af viruskappeproteinet, fremgangsmåde til detektion af AIDS-antistoffer, fremgangsmåde til bestemmelse af AIDS-virus, vaccine mod AIDS, antistoffer mod viruskappeproteinet samt anvendelse af dette til fremstilling af en vaccine og til testnin
|
|
WO1987002775A1
(en)
|
1985-10-24 |
1987-05-07 |
Southwest Foundation For Biomedical Research |
Synthetic peptides and use for diagnosis and vaccination for aids and arc
|
|
EP0242216A1
(en)
|
1986-04-16 |
1987-10-21 |
THE UNITED STATES OF AMERICA as represented by the Secretary United States Department of Commerce |
Non-cytopathic clone of Human T-Cell Lymphotropic Virus type III
|
|
WO1988000471A1
(en)
|
1986-07-21 |
1988-01-28 |
Southwest Foundation For Biomedical Research |
Composition of matter and method of immunizing against viral causative agents of aids and arc
|
|
US4861707A
(en)
|
1987-02-02 |
1989-08-29 |
E. I. Du Pont De Nemours And Company |
Human immunodeficiency virus antigen
|
|
US5256767A
(en)
|
1987-06-10 |
1993-10-26 |
The Immune Response Corporation |
Retroviral antigens
|
|
EP0299242A3
(en)
|
1987-06-22 |
1989-01-25 |
Medico Labs Ag |
Heterologous viral peptide particle immunogens
|
|
KR890701605A
(ko)
|
1987-07-04 |
1989-12-21 |
원본미기재 |
Dna 서열, 재조합 dna 분자 및 용해성 t4 단백질의 제조방법
|
|
US5637677A
(en)
|
1987-07-16 |
1997-06-10 |
The Trustees Of The University Of Pennsylvania |
Biologically active compounds and methods of constructing and using the same
|
|
AU2914889A
(en)
|
1987-08-28 |
1989-04-17 |
Board Of Regents, The University Of Texas System |
Prophylaxis and therapy of acquired immunodeficiency syndrome
|
|
US5128319A
(en)
|
1987-08-28 |
1992-07-07 |
Board Of Regents, The University Of Texas System |
Prophylaxis and therapy of acquired immunodeficiency syndrome
|
|
US5879907A
(en)
|
1987-09-14 |
1999-03-09 |
Skandigen Ab |
Artificial gene coding for authentic human serum albumin, use thereof and method
|
|
PT88641B
(pt)
|
1987-10-02 |
1993-04-30 |
Genentech Inc |
Metodo para a preparacao de uma variante de adesao
|
|
IL87902A0
(en)
|
1987-10-08 |
1989-03-31 |
Dana Farber Cancer Inst Inc |
Soluble human cd4 fragments and applications thereof
|
|
US5714596A
(en)
|
1987-11-18 |
1998-02-03 |
Chiron Corporation |
NANBV diagnostics: polynucleotides useful for screening for hepatitis C virus
|
|
US5683864A
(en)
|
1987-11-18 |
1997-11-04 |
Chiron Corporation |
Combinations of hepatitis C virus (HCV) antigens for use in immunoassays for anti-HCV antibodies
|
|
US5712088A
(en)
|
1987-11-18 |
1998-01-27 |
Chiron Corporation |
Methods for detecting Hepatitis C virus using polynucleotides specific for same
|
|
US5204259A
(en)
|
1988-05-06 |
1993-04-20 |
Pharmacia Genetic Engineering, Inc. |
Methods and systems for producing HIV antigens
|
|
CA1340748C
(en)
|
1988-07-13 |
1999-09-14 |
Stephen Oroszlan |
Synthetic hiv protease gene and method for its expression
|
|
EP0434713B1
(en)
|
1988-09-13 |
1994-10-12 |
Chiron Corporation |
Hiv-1 envelope muteins lacking hypervariable domains
|
|
IL91843A0
(en)
|
1988-10-03 |
1990-06-10 |
Repligen Corp |
Hiv proteins and peptides useful in the diagnosis,prophylaxis aids or therapy of aids
|
|
CA2003383A1
(en)
|
1988-11-23 |
1990-05-23 |
Sushil G. Devare |
Synthetic dna derived recombinant hiv antigens
|
|
AU5184190A
(en)
|
1989-02-23 |
1990-09-26 |
University Of Ottawa |
Polypeptide having immunological activity for use as diagnostic reagent and/or vaccine
|
|
US5082767A
(en)
|
1989-02-27 |
1992-01-21 |
Hatfield G Wesley |
Codon pair utilization
|
|
IL93682A
(en)
|
1989-03-16 |
1996-06-18 |
Yeda Res & Dev |
Polycyclic compounds with antigypical activity are used in the manufacture of medicines and pharmaceutical preparations containing them
|
|
WO1990011359A1
(en)
|
1989-03-20 |
1990-10-04 |
Whitehead Institute For Biomedical Research |
Intracellular method of inhibiting hiv in mammalian cells
|
|
US6214804B1
(en)
|
1989-03-21 |
2001-04-10 |
Vical Incorporated |
Induction of a protective immune response in a mammal by injecting a DNA sequence
|
|
ES2116269T3
(es)
|
1989-03-21 |
1998-07-16 |
Vical Inc |
Expresion de secuencias exogenas de polinucleotidos en un vertebrado.
|
|
AU5421090A
(en)
|
1989-04-05 |
1990-11-05 |
United States of America, as represented by the Secretary, U.S. Department of Commerce, The |
A clone of double-stranded rna virus and applications thereof
|
|
EP1288304A3
(en)
|
1989-06-01 |
2006-04-05 |
Applied Biotechnology, Inc. |
Self-assembled, defective, non-self-propagating viral particles
|
|
US5130247A
(en)
|
1989-09-19 |
1992-07-14 |
Merck & Co., Inc. |
Expression of fusion protein of HIV envelope and HBsAG
|
|
AU6523590A
(en)
|
1989-09-22 |
1991-04-18 |
Idec Pharmaceuticals Corporation |
Novel peptides associated with the cd4 binding region of gp120 and their methods of use
|
|
ES2072346T3
(es)
|
1989-10-23 |
1995-07-16 |
Hoffmann La Roche |
Peptidos sinteticos de la cubierta del htlv-i.
|
|
AU6642390A
(en)
|
1989-10-27 |
1991-05-31 |
Arch Development Corporation |
Methods and compositions for promoting immunopotentiation
|
|
WO1991007510A1
(en)
|
1989-11-17 |
1991-05-30 |
Amgen Inc. |
A method of detecting htlv-i antibodies in human body fluids
|
|
WO1991007425A1
(en)
|
1989-11-20 |
1991-05-30 |
Oncogen Limited Partnership |
Non-replicating recombinant-made retroviral particles used as antiviral agents and immunogens
|
|
SE468168B
(sv)
|
1990-02-20 |
1992-11-16 |
Replico Medical Ab |
Hiv-1, p24 peptider, diagnostiska antigener och foerfarande foer saerskiljande diagnostik av preliminaert hiv-1 positiva serumprov
|
|
DE69132795T3
(de)
|
1990-03-09 |
2008-07-10 |
Novartis Vaccines and Diagnostics, Inc., Emeryville |
Gereinigtes gp120, in dem seine natürliche konformation erhalten bleibt
|
|
US5876724A
(en)
|
1990-03-19 |
1999-03-02 |
Institut Pasteur |
Induction of neutralizing antibody against viral infection by synergy between virus envelope glycoprotein and peptides corresponding to neutralization epitopes of the glycoprotein
|
|
EP0449116B2
(en)
|
1990-03-21 |
2004-08-25 |
Geneart GmbH |
DNA sequences encoding modified retroviral gag polypeptides and vaccines containing them or aggregates thereof
|
|
WO1991015238A1
(en)
|
1990-04-03 |
1991-10-17 |
Genentech, Inc. |
Methods and compositions for vaccination against hiv
|
|
CA2078545A1
(en)
|
1990-04-03 |
1991-10-04 |
Timothy J. Gregory |
Hiv envelope polypeptides
|
|
IL97985A0
(en)
|
1990-05-07 |
1992-06-21 |
North American Vaccine Inc |
Improved vaccine compositions
|
|
AP237A
(en)
|
1990-05-29 |
1993-04-29 |
Cedars Sinai Medical Center |
Immunoreagents reactive with a conserved epitope of human immunodeficiency virus type 1 (HIV-1) gp120 and methods of use.
|
|
WO1991019803A1
(en)
|
1990-06-19 |
1991-12-26 |
Applied Biotechnology, Incorporated |
Self assembled, defective, nonself-propagating viral particles
|
|
WO1992004046A1
(en)
|
1990-08-29 |
1992-03-19 |
The United States Of America, Represented By The Secretary, United States Department Of Commerce |
Novel peptide antigens and immunoassays, test kits and vaccines using the same
|
|
US5840313A
(en)
|
1990-09-27 |
1998-11-24 |
Syntello Vaccine Development Kb |
Peptides for use in vaccination and induction of neutralizing antibodies against human immunodeficiency virus
|
|
WO1992005799A1
(en)
|
1990-09-28 |
1992-04-16 |
Hospital For Joint Diseases |
Method for inhibiting the infectivity of human immunodeficiency virus
|
|
CA2405246A1
(en)
|
1990-12-03 |
1992-06-11 |
Genentech, Inc. |
Enrichment method for variant proteins with alterred binding properties
|
|
IE920366A1
(en)
|
1991-02-04 |
1992-08-12 |
Univ Saskatchewan |
Vp6 encapsulated drug delivery
|
|
JPH06508821A
(ja)
|
1991-03-07 |
1994-10-06 |
セラジュン インク |
ウイルス病治療のための細胞表面受容体を標的とする分子の使用
|
|
US6139843A
(en)
|
1991-04-02 |
2000-10-31 |
Albert Einstein College Of Medicine Of Yeshiva University |
Peptide compositions for the treatment of HIV
|
|
AU2412692A
(en)
|
1991-07-23 |
1993-02-23 |
Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The |
Novel peptide antigens and immunoassays, test kits and vaccines using the same
|
|
US5558865A
(en)
|
1991-08-22 |
1996-09-24 |
Nissin Shokuhin Kabushiki Kaisha |
HIV immunotherapeutics
|
|
AU659677B2
(en)
|
1991-08-22 |
1995-05-25 |
Nissin Shokuhin Kabushiki Kaisha |
HIV immunotherapeutics
|
|
WO1993006126A1
(en)
|
1991-09-13 |
1993-04-01 |
Chiron Corporation |
Immunoreactive hepatitis c virus polypeptide compositions
|
|
EP0613378A1
(en)
|
1991-10-28 |
1994-09-07 |
Institut Pasteur |
Induction of protection against viral infection by synergy between viral proteins and viral peptides
|
|
AU3483293A
(en)
|
1992-01-22 |
1993-09-01 |
New England Medical Center Hospitals, Inc., The |
Pathogen-specific CTL therapy
|
|
US5174666A
(en)
|
1992-02-12 |
1992-12-29 |
Smith Corona Corporation |
Printing device having printwheel coupling means
|
|
US6174666B1
(en)
|
1992-03-27 |
2001-01-16 |
The United States Of America As Represented By The Department Of Health And Human Services |
Method of eliminating inhibitory/instability regions from mRNA
|
|
EP0644950A4
(en)
|
1992-04-09 |
1997-05-14 |
Abbott Lab |
ASSAY FOR THE DETECTION OF HIV ANTIGEN AND HIV ANTIBODIES.
|
|
EP0642589A4
(en)
|
1992-05-11 |
1997-05-21 |
Ribozyme Pharm Inc |
METHOD AND REAGENT TO INHIBIT VIRAL REPLICATION.
|
|
US5665720A
(en)
|
1992-08-07 |
1997-09-09 |
Merck & Co., Inc. |
Benzoxazinones as inhibitors of HIV reverse transcriptase
|
|
DE4228458A1
(de)
|
1992-08-27 |
1994-06-01 |
Beiersdorf Ag |
Multicistronische Expressionseinheiten und deren Verwendung
|
|
FR2695563B1
(fr)
|
1992-09-11 |
1994-12-02 |
Pasteur Institut |
Microparticules portant des antigènes et leur utilisation pour l'induction de réponses humorales ou cellulaires.
|
|
US6004763A
(en)
|
1992-09-11 |
1999-12-21 |
Institut Pasteur |
Antigen-carrying microparticles and their use in the induction of humoral or cellular responses
|
|
US5686078A
(en)
|
1992-09-14 |
1997-11-11 |
Connaught Laboratories, Inc. |
Primary and secondary immunization with different physio-chemical forms of antigen
|
|
CA2105629A1
(en)
|
1992-09-14 |
1994-03-15 |
Robert S. Becker |
Potentiation of immunogenic response
|
|
JPH08502260A
(ja)
|
1992-09-30 |
1996-03-12 |
ザ スクリップス リサーチ インスティテュート |
ヒト免疫不全ウイルスに対するヒト中和モノクローナル抗体
|
|
US5652138A
(en)
|
1992-09-30 |
1997-07-29 |
The Scripps Research Institute |
Human neutralizing monoclonal antibodies to human immunodeficiency virus
|
|
US5648267A
(en)
|
1992-11-13 |
1997-07-15 |
Idec Pharmaceuticals Corporation |
Impaired dominant selectable marker sequence and intronic insertion strategies for enhancement of expression of gene product and expression vector systems comprising same
|
|
US5304472A
(en)
|
1992-11-20 |
1994-04-19 |
Genentech, Inc. |
Method of controlling polypeptide production in bacterial cells
|
|
ATE199392T1
(de)
|
1992-12-04 |
2001-03-15 |
Medical Res Council |
Multivalente und multispezifische bindungsproteine, deren herstellung und verwendung
|
|
WO1994016060A1
(en)
|
1993-01-11 |
1994-07-21 |
The Trustees Of The University Of Pennsylvania |
Mutants of hiv for supression of hiv infection
|
|
EP0678029A1
(en)
|
1993-01-13 |
1995-10-25 |
BURCOGLU, Arsinur |
Method for using polynucleotides, oligonucleotides and derivatives thereof to treat various disease states
|
|
DK0679187T4
(da)
|
1993-01-16 |
2001-09-17 |
Manfred Schawaller |
Fremgangsmåde til udvinding af native, oligomere, glycosylerede ektodomæner fra virale membranproteiner, og deres anvendelse, især som vaccine mod HIV
|
|
US5593972A
(en)
|
1993-01-26 |
1997-01-14 |
The Wistar Institute |
Genetic immunization
|
|
AU675702B2
(en)
|
1993-01-26 |
1997-02-13 |
Leslie R. Coney |
Compositions and methods for delivery of genetic material
|
|
AU6235294A
(en)
|
1993-02-02 |
1994-08-29 |
Scripps Research Institute, The |
Methods for producing polypeptide binding sites
|
|
WO1994020640A1
(en)
|
1993-03-05 |
1994-09-15 |
Genelabs Technologies, Inc. |
Method for hiv quantitation
|
|
WO1994020141A1
(en)
|
1993-03-11 |
1994-09-15 |
The University Of Southern California |
Therapeutic strategies for immunoinfective cluster virus infections
|
|
US5869624A
(en)
|
1993-03-26 |
1999-02-09 |
Progenics Pharmaceuticals, Inc. |
HIV-1 vaccines, antibody compositions related thereto, and therapeutic and prophylactic uses thereof
|
|
WO1994023069A1
(en)
|
1993-03-26 |
1994-10-13 |
Gen-Probe Incorporated |
Detection of human immunodeficiency virus type 1
|
|
AU6816194A
(en)
|
1993-04-20 |
1994-11-08 |
Robinson, William S. |
Methods and materials for treatment of individuals infected with intracellular infectious agents
|
|
US5419900A
(en)
|
1993-05-19 |
1995-05-30 |
The United States Of America As Represented By The Department Of Of Health And Human Services |
Immunologic enhancement with intermittent interleukin-2 therapy
|
|
EP0708659A4
(en)
|
1993-06-07 |
2000-08-23 |
Genentech Inc |
HIV ENVELOPE POLYPEPTIDES
|
|
CA2164818C
(en)
|
1993-06-09 |
2003-09-23 |
Charles D.Y. Sia |
Tandem synthetic hiv-1 peptides
|
|
CA2125344A1
(en)
|
1993-07-01 |
1995-01-02 |
Casey D. Morrow |
Encapsidated recombinant poliovirus nucleic acid and methods of making and using same
|
|
US5614413A
(en)
|
1993-07-01 |
1997-03-25 |
The Uab Research Foundation |
Encapsidated recombinant poliovirus nucleic acid and methods of making and using same
|
|
JPH09501562A
(ja)
|
1993-07-19 |
1997-02-18 |
ジェン−プローブ・インコーポレイテッド |
ヒト・免疫不全ウイルスに対する活性を有するオリゴヌクレオチド
|
|
WO1995004818A1
(en)
|
1993-08-06 |
1995-02-16 |
Ribozyme Pharmaceuticals, Inc. |
Method and reagent for inhibiting human immunodeficiency virus replication
|
|
DE69435126D1
(de)
|
1993-10-19 |
2008-10-02 |
Scripps Research Inst |
Synthetische humane neutralisierende monoklonale antikörper gegen hiv
|
|
WO1995011701A1
(en)
|
1993-10-26 |
1995-05-04 |
Syntello, Inc. |
Inhibition of hiv mucosal infection
|
|
IL112820A0
(en)
|
1994-03-07 |
1995-05-26 |
Merck & Co Inc |
Coordinate in vivo gene expression
|
|
JPH10504798A
(ja)
|
1994-03-14 |
1998-05-12 |
ユニバーシティー オブ サウザーン カリフォルニア |
Hiv−1感染の診断方法および処置方法
|
|
WO1995027505A1
(en)
|
1994-04-12 |
1995-10-19 |
Biomira, Inc. |
Cellular immune response-specific antigens and uses therefor
|
|
ATE221786T1
(de)
|
1994-04-29 |
2002-08-15 |
Univ Duke |
Synthetischer impfstoff zum schutz gegen infektionen mit dem menschlichen immunschwächevirus
|
|
JPH10502165A
(ja)
|
1994-05-31 |
1998-02-24 |
アボツト・ラボラトリーズ |
合成ペプチド−改良イムノアッセイを使用する異なるhiv遺伝子型の検出
|
|
CA2191362A1
(en)
|
1994-06-02 |
1995-12-14 |
Mark Selby |
Nucleic acid immunization using a virus-based infection/transfection system
|
|
US5733781A
(en)
|
1994-07-19 |
1998-03-31 |
Gen-Probe Incorporated |
Oligonucleotides and methods for inhibiting propagation of human immunodeficiency virus
|
|
US5955342A
(en)
|
1994-08-15 |
1999-09-21 |
Connaught Laboratories Limited |
Non-infectious, replication-defective, self-assembling HIV-1 viral particles containing antigenic markers in the gag coding region
|
|
US6291157B1
(en)
|
1998-02-23 |
2001-09-18 |
Connaught Laboratories Limited |
Antigenically-marked non-infectious retrovirus-like particles
|
|
US6080408A
(en)
|
1994-08-22 |
2000-06-27 |
Connaught Laboratories Limited |
Human immunodeficiency virus type 1 nucleic acids devoid of long terminal repeats capable of encoding for non-infectious, immunogenic, retrovirus-like particles
|
|
US5795737A
(en)
|
1994-09-19 |
1998-08-18 |
The General Hospital Corporation |
High level expression of proteins
|
|
US5786464C1
(en)
*
|
1994-09-19 |
2012-04-24 |
Gen Hospital Corp |
Overexpression of mammalian and viral proteins
|
|
AU3593095A
(en)
|
1994-09-23 |
1996-04-09 |
Johns Hopkins University School Of Medicine, The |
Method of treatment of human immunodeficiency virus (hiv) infection
|
|
WO1996016178A1
(en)
|
1994-11-17 |
1996-05-30 |
Maxim Pharmaceuticals, Inc. |
Immunogens for stimulating mucosal immunity
|
|
US5550280A
(en)
|
1994-11-30 |
1996-08-27 |
Uniroyal Chemical Ltd./ Uniroyal Chemical Ltee |
Hindered aromatic ester compounds useful as anti-viral agents
|
|
JPH10512243A
(ja)
|
1994-12-30 |
1998-11-24 |
カイロン コーポレイション |
遺伝子送達ビヒクルの非外傷性投与
|
|
US6689761B1
(en)
|
1995-02-01 |
2004-02-10 |
Merck & Co., Inc. |
Combination therapy for HIV infection
|
|
FR2730411B1
(fr)
|
1995-02-14 |
1997-03-28 |
Centre Nat Rech Scient |
Association medicamenteuse utile pour la transfection et l'expression in vivo d'exogenes
|
|
WO1996030523A2
(en)
|
1995-03-31 |
1996-10-03 |
Hans Wolf |
Antigen presentation system based on retrovirus-like particles
|
|
US6251405B1
(en)
|
1995-06-07 |
2001-06-26 |
Connaught Laboratories, Inc. |
Immunological combination compositions and methods
|
|
US5797870A
(en)
|
1995-06-07 |
1998-08-25 |
Indiana University Foundation |
Pericardial delivery of therapeutic and diagnostic agents
|
|
WO1997003198A2
(en)
|
1995-07-07 |
1997-01-30 |
Texas A & M University System |
Nucleotide and amino acid sequence and uses thereof
|
|
NZ319891A
(en)
|
1995-09-28 |
1999-01-28 |
Univ Pittsburgh |
Stimulation of cytotoxic t lymphocyte response to tumour or virus by targeted particulate polynucleotide genetic immunisation
|
|
CU22559A1
(es)
|
1996-01-17 |
1999-05-03 |
Ct Ingenieria Genetica Biotech |
Sistema de expresión de antígenos heterologos en e. coli como proteínas de fusión
|
|
WO1997026009A1
(en)
|
1996-01-17 |
1997-07-24 |
Progenics Pharmaceuticals, Inc. |
Compounds capable of inhibiting hiv-1 infection
|
|
US5741492A
(en)
|
1996-01-23 |
1998-04-21 |
St. Jude Children's Research Hospital |
Preparation and use of viral vectors for mixed envelope protein vaccines against human immunodeficiency viruses
|
|
US6087486A
(en)
|
1996-01-29 |
2000-07-11 |
The Trustees Of The University Of Pennsylvania |
Nucleotide sequences encoding vpr receptor protein
|
|
US6060587A
(en)
|
1996-01-29 |
2000-05-09 |
The Trustees Of The University Of Pennsylvania |
Cellular receptor for HIV-1 VPR essential for G2/M phase transition of the cell cycle
|
|
US5649652A
(en)
|
1996-02-16 |
1997-07-22 |
Sackett; Eleanor L. |
Clothes hanger with storage hook
|
|
JP2000505299A
(ja)
*
|
1996-02-22 |
2000-05-09 |
メルク エンド カンパニー インコーポレーテッド |
合成hiv遺伝子
|
|
US6451592B1
(en)
|
1996-04-05 |
2002-09-17 |
Chiron Corporation |
Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis
|
|
CA2258568A1
(en)
|
1996-06-21 |
1997-12-24 |
Merck & Co., Inc. |
Vaccines comprising synthetic genes
|
|
US5951975A
(en)
|
1996-06-28 |
1999-09-14 |
University Of Pittsburgh |
Induction of CTLs specific for natural antigens by cross priming immunization
|
|
EP0942747A1
(en)
|
1996-08-26 |
1999-09-22 |
Chiron Corporation |
Postinfection human immunodeficiency virus (hiv) vaccination therapy
|
|
ATE229073T1
(de)
|
1996-09-06 |
2002-12-15 |
Univ California |
Protein e25a, methoden zu dessen herstellung und anwendung
|
|
US6114148C1
(en)
|
1996-09-20 |
2012-05-01 |
Gen Hospital Corp |
High level expression of proteins
|
|
US6139833A
(en)
|
1997-08-08 |
2000-10-31 |
Lexicon Genetics Incorporated |
Targeted gene discovery
|
|
US5830697A
(en)
|
1997-01-21 |
1998-11-03 |
The Board Of Trustees Of The Leland Stanford Junior University |
P-glycoprotein mutant resistant to cyclosporin modulation
|
|
DK0969862T3
(da)
*
|
1997-02-07 |
2007-02-12 |
Merck & Co Inc |
Syntetisk HIV gag-gener
|
|
US5990091A
(en)
|
1997-03-12 |
1999-11-23 |
Virogenetics Corporation |
Vectors having enhanced expression, and methods of making and uses thereof
|
|
AU6535898A
(en)
|
1997-03-14 |
1998-10-12 |
President And Fellows Of Harvard College |
Glycosylation deficient siv and hiv envelope glycoproteins
|
|
ES2242997T3
(es)
|
1997-03-14 |
2005-11-16 |
Biogen Idec Inc. |
Metodo para integrar genes en sitios especificos en celulas de mamifero por medio de recombinacion homologa y vectores para realizar el mismo.
|
|
IL131843A
(en)
|
1997-03-24 |
2004-06-20 |
Univ Kingston |
A method for detecting coincidences, products and devices
|
|
HK1044896A1
(zh)
|
1997-04-28 |
2002-11-08 |
Burcoglu Arsinur |
治疗hiv感染和与之有关的继发感染的方法
|
|
US5858675A
(en)
|
1997-05-13 |
1999-01-12 |
Incyte Pharmaceuticals, Inc. |
Double-stranded RNA-binding protein
|
|
US6099847A
(en)
|
1997-05-15 |
2000-08-08 |
The United States Of America As Represented By The Department Of Health And Human Services |
Chimeric Gag pseudovirions
|
|
WO1998059074A1
(en)
|
1997-06-23 |
1998-12-30 |
Emory University |
Human immunodeficiency viruses causing aids in a nonhuman primate
|
|
EP1002091B1
(en)
|
1997-07-09 |
2012-02-29 |
Coridon Pty Limited |
Nucleic acid sequence and method for selectively expressing a protein in a target cell or tissue
|
|
ATE360709T1
(de)
|
1997-08-01 |
2007-05-15 |
Genetic Systems Corp |
Synthetische antigene zum nachweis von antikörpern mit immunreaktivität gegen hiv-virus
|
|
US6287568B1
(en)
|
1997-09-09 |
2001-09-11 |
The Trustees Of Columbia University In The City Of New York |
Methods relating to immunogenic dextran-protein conjugates
|
|
WO1999013864A2
(en)
|
1997-09-19 |
1999-03-25 |
Shire Laboratories, Inc. |
Solid solution beadlet
|
|
US5932442A
(en)
|
1997-09-23 |
1999-08-03 |
Incyte Pharmaceuticals, Inc. |
Human regulatory molecules
|
|
US5932445A
(en)
|
1997-11-07 |
1999-08-03 |
Incyte Pharmaceuticals, Inc. |
Signal peptide-containing proteins
|
|
FR2773156B1
(fr)
|
1997-12-26 |
2000-03-31 |
Biovacs Inc |
Nouveaux immunogenes anti-retroviraux (toxoides), nouveaux procedes de preparation et application a la prevention et au traitement du sida
|
|
WO1999041398A1
(en)
|
1998-02-11 |
1999-08-19 |
Genvec, Inc. |
Vectors, cells and methods for the production of deleterious viral eukaryotic gene transfer vectors
|
|
GB9803351D0
(en)
|
1998-02-17 |
1998-04-15 |
Oxford Biomedica Ltd |
Anti-viral vectors
|
|
AU3745599A
(en)
|
1998-04-14 |
1999-11-01 |
Chiron Corporation |
Noncloning technique for expressing a gene of interest
|
|
JP2002511396A
(ja)
|
1998-04-14 |
2002-04-16 |
メルク エンド カムパニー インコーポレーテッド |
ポリヌクレオチド製剤の無針投与
|
|
DE69929432T2
(de)
|
1998-04-22 |
2006-09-28 |
Chiron Corp. (N.D.Ges.D. Staates Delaware), Emeryville |
Erhöhung der immunantworten bei genetischer immunisierung durch verwendung eines chemokins
|
|
US6090388A
(en)
|
1998-06-20 |
2000-07-18 |
United Biomedical Inc. |
Peptide composition for prevention and treatment of HIV infection and immune disorders
|
|
FR2780069B1
(fr)
|
1998-06-23 |
2002-06-28 |
Inst Nat Sante Rech Med |
Famille de sequences nucleiques et de sequences proteiques deduites presentant des motifs retroviraux endogenes humains et leurs applications
|
|
AU5771599A
(en)
|
1998-08-03 |
2000-02-28 |
University Of Montana, The |
Prevention and treatment of viral disease
|
|
AU6139699A
(en)
*
|
1998-09-11 |
2000-04-03 |
Children's Medical Center Corporation |
Packaging cell lines for hiv-derived retroviral vector particles
|
|
AU5980899A
(en)
|
1998-09-25 |
2000-04-17 |
Smithkline Beecham Biologicals (Sa) |
Novel compounds
|
|
EP1117433A1
(en)
|
1998-10-09 |
2001-07-25 |
Dynavax Technologies Corporation |
Anti hiv compositions comprising immunostimulatory polynucleotides and hiv antigens
|
|
US6489542B1
(en)
|
1998-11-04 |
2002-12-03 |
Monsanto Technology Llc |
Methods for transforming plants to express Cry2Ab δ-endotoxins targeted to the plastids
|
|
AU2487300A
(en)
|
1998-12-31 |
2000-07-31 |
Chiron Corporation |
Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
|
|
ES2299276T3
(es)
|
1998-12-31 |
2008-05-16 |
Novartis Vaccines And Diagnostics, Inc. |
Polipeptidos env del vih modificados.
|
|
WO2000039302A2
(en)
*
|
1998-12-31 |
2000-07-06 |
Chiron Corporation |
Improved expression of hiv polypeptides and production of virus-like particles
|
|
ATE434051T1
(de)
|
1999-01-27 |
2009-07-15 |
Stratagene California |
Hohe expression eines heterologen proteins mit seltenen codons
|
|
WO2000029561A2
(en)
|
1999-03-29 |
2000-05-25 |
Statens Serum Institut |
Nucleotide construct with optimised codons for an hiv genetic vaccine based on a primary, early hiv isolate and synthetic envelope
|
|
PL351988A1
(en)
|
1999-04-26 |
2003-07-14 |
Leuven K U Res & Dev |
Synthetic gene for expressing active retroviral protein in eukaryotes
|
|
EP1181057B1
(en)
|
1999-05-03 |
2012-08-01 |
The Uab Research Foundation |
Noninvasive genetic immunization, expression products therefrom, and uses thereof
|
|
WO2000067787A2
(en)
|
1999-05-06 |
2000-11-16 |
The Immune Response Corporation |
Hiv immunogenic compositions and methods
|
|
KR100873157B1
(ko)
|
1999-05-06 |
2008-12-10 |
웨이크 포리스트 유니버시티 |
면역 반응을 유발하는 항원을 동정하기 위한 조성물과 방법
|
|
US6420545B1
(en)
|
1999-05-24 |
2002-07-16 |
The Trustees Of The University Of Pennsylvania |
CD4-independent HIV envelope proteins as vaccines and therapeutics
|
|
US6280989B1
(en)
|
1999-06-17 |
2001-08-28 |
Dmitri Kapitonov |
Sialyltransferases
|
|
CA2378539A1
(en)
|
1999-07-06 |
2001-01-11 |
Merck & Co., Inc. |
Adenovirus carrying gag gene hiv vaccine
|
|
CA2380947C
(en)
|
1999-08-19 |
2011-11-01 |
Dynavax Technologies Corporation |
Methods of modulating an immune response using immunostimulatory sequences and compositions for use therein
|
|
CA2392010A1
(en)
|
1999-08-27 |
2001-03-08 |
Regents Of The University Of California |
Use of lentiviral vectors for antigen presentation in dendritic cells
|
|
WO2001019958A2
(en)
|
1999-09-17 |
2001-03-22 |
Dana-Farber Cancer Institute, Inc. |
Stabilized soluble glycoprotein trimers
|
|
WO2001021270A2
(en)
|
1999-09-21 |
2001-03-29 |
Prodigene, Inc. |
Methods for producing recombinant proteins
|
|
DE60043708D1
(de)
|
1999-10-13 |
2010-03-04 |
Novartis Vaccines & Diagnostic |
Verfahren zur erhaltung zellimmuneantworten gegen proteinen
|
|
WO2001029225A1
(en)
|
1999-10-21 |
2001-04-26 |
Panorama Research, Inc. |
A general method for optimizing the expression of heterologous proteins
|
|
JP2003513635A
(ja)
|
1999-11-01 |
2003-04-15 |
カイロン コーポレイション |
発現ベクター、トランスフェクション系、およびそれらの使用方法
|
|
PL358811A1
(en)
|
1999-11-13 |
2004-08-23 |
Merck Patent Gmbh |
High order nucleic acid based structures
|
|
AU2841101A
(en)
|
1999-12-08 |
2001-06-18 |
Novartis Ag |
Methods and compositions useful for inhibiting ccr5-dependent infection of cellsby hiv-1
|
|
AU782193B2
(en)
|
1999-12-17 |
2005-07-07 |
Merck & Co., Inc. |
Polynucleotide vaccines expressing codon optimized HIV-1 Nef and modified HIV-1 Nef
|
|
EP1242124A4
(en)
|
1999-12-22 |
2004-07-14 |
Merck & Co Inc |
POLYNUCLEOTIDE VACCINES EXPRESSING CODONE-OPTIMIZED HIV-1 POL AND MODIFIED HIV-1 POL
|
|
AU784679B2
(en)
|
1999-12-23 |
2006-05-25 |
International Aids Vaccine Initiative |
Improvements in or relating to immune responses to HIV
|
|
WO2001046408A2
(en)
|
1999-12-23 |
2001-06-28 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Molecular clones with mutated hiv gag/pol, siv gag and siv env genes
|
|
WO2001054719A2
(en)
|
2000-01-31 |
2001-08-02 |
Smithkline Beecham Biologicals S.A. |
Vaccine for the prophylactic or therapeutic immunization against hiv
|
|
AU2001233063A1
(en)
|
2000-01-31 |
2001-08-07 |
Aaron Diamond Aids Research Center |
Vaccination of hiv infected persons following highly active antiretroviral therapy
|
|
WO2001060393A1
(en)
|
2000-02-16 |
2001-08-23 |
Bechtel Bwxt Idaho, Llc |
Selective destruction of cells infected with human immunodeficiency virus
|
|
JP2003523188A
(ja)
|
2000-02-18 |
2003-08-05 |
ユニバーシティ・オブ・ワシントン |
Aids先祖ウイルスおよびワクチン
|
|
MXPA03002640A
(es)
|
2000-09-28 |
2003-06-19 |
Chiron Corp |
Microparticulas para la distribucion de acidos nucleicos heterologos.
|
|
AU2002320314A1
(en)
|
2001-07-05 |
2003-01-21 |
Chiron, Corporation |
Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
|